Table 3.
The correlation between the clinical characteristics and the expression of FABP7
| Characteristic | Low expression of FABP7 | High expression of FABP7 | P value | Method |
|---|---|---|---|---|
| n | 541 | 542 | ||
| T stage, n (%) | 0.014 | Chisq.test | ||
| T1 | 125 (11.6%) | 152 (14.1%) | ||
| T2 | 325 (30.1%) | 304 (28.1%) | ||
| T3 | 64 (5.9%) | 75 (6.9%) | ||
| T4 | 25 (2.3%) | 10 (0.9%) | ||
| N stage, n (%) | 0.694 | Chisq.test | ||
| N0 | 247 (23.2%) | 267 (25.1%) | ||
| N1 | 177 (16.6%) | 181 (17%) | ||
| N2 | 62 (5.8%) | 54 (5.1%) | ||
| N3 | 40 (3.8%) | 36 (3.4%) | ||
| M stage, n (%) | 0.258 | Chisq.test | ||
| M0 | 448 (48.6%) | 454 (49.2%) | ||
| M1 | 13 (1.4%) | 7 (0.8%) | ||
| Age, meidan (IQR) | 61 (50, 70) | 55 (47, 64) | < 0.001 | Wilcoxon |